Photo: Dr Jaesung Peter Choi receives the award from Dr Brent Derry.
Centenary Institute researcher Dr Jaesung Peter Choi has been awarded “The FEBS Journal Poster Prize” at the 14th Annual Angioma Alliance CCM Scientific Meeting, held in Washington DC. The prize recognises the best poster presentation by a trainee.
Dr Choi was able to attend the meeting after receiving the Australian Vascular Biology Society (AVBS) Travel Award.
He was joined by Head of Centenary’s Cell Signalling Laboratory, Dr Xiangjian (XJ) Zheng.
The pair presented their most recent study, published in the scientific journal Science Advances, which identified a cancer drug as a potential treatment option for Cerebral Cavernous Malformations (CCM) – a leading cause of stroke in young people.
— Dr Jaesung Peter Choi (@JaesungPeter) November 15, 2018
Research from the Centenary Institute has found that the human enzyme DPP4 does not enable COVID-19 infection in our bodies.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.